133 related articles for article (PubMed ID: 37178250)
1. Study on the Mechanism of Levofloxacin Combined with Imipenem Against Pseudomonas aeruginosa.
Lu Q; Yang Q
Appl Biochem Biotechnol; 2024 Feb; 196(2):690-700. PubMed ID: 37178250
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
Lister PD; Wolter DJ; Wickman PA; Reisbig MD
J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
Lister PD; Wolter DJ
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S105-14. PubMed ID: 15712098
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa.
Wang L; Zhou X; Lu Y; Zhang X; Jiang J; Sun Z; Yin M; Doi Y; Wang M; Guo Q; Yang F
Int J Antimicrob Agents; 2024 May; 63(5):107119. PubMed ID: 38417706
[TBL] [Abstract][Full Text] [Related]
5. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kaynar-Tascioglu J; Kaya B; Goktas P
Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Khan M; Ma K; Wan I; Willcox MD
Cont Lens Anterior Eye; 2023 Jun; 46(3):101819. PubMed ID: 36732125
[TBL] [Abstract][Full Text] [Related]
7. Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.
Safarika A; Galani I; Pistiki A; Giamarellos-Bourboulis EJ
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):317-23. PubMed ID: 25192733
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
Nazli E; Zer Y; Eksi F
J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.
Zhang Y; Zhao J; Han J; Fan Y; Xiong Z; Zou X; Li B; Liu X; Li Z; Lu B; Cao B
Microbiol Spectr; 2022 Apr; 10(2):e0274021. PubMed ID: 35315696
[TBL] [Abstract][Full Text] [Related]
11. Imipenem resistance associated with amino acid alterations of the OprD porin in Pseudomonas aeruginosa clinical isolates.
Nazari M; Ahmadi H; Hosseinzadeh S; Sahebkar A; Khademi F
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):206-212. PubMed ID: 37342895
[TBL] [Abstract][Full Text] [Related]
12. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Shahri FN; Izanloo A; Goharrizi MASB; Jamali A; Bagheri H; Hjimohammadi A; Ardebili A
Int Microbiol; 2022 Nov; 25(4):709-721. PubMed ID: 35697891
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.
McGrath BJ; Lamp KC; Rybak MJ
Antimicrob Agents Chemother; 1993 Sep; 37(9):1931-7. PubMed ID: 8239608
[TBL] [Abstract][Full Text] [Related]
15. Comparative In Vitro Efficacy of Doripenem and Imipenem Against Multi-Drug Resistant Pseudomonas aeruginosa.
Wali N; Mirza IA
J Coll Physicians Surg Pak; 2016 Apr; 26(4):297-301. PubMed ID: 27097701
[TBL] [Abstract][Full Text] [Related]
16. Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Moyá B; Beceiro A; Cabot G; Juan C; Zamorano L; Alberti S; Oliver A
Antimicrob Agents Chemother; 2012 Sep; 56(9):4771-8. PubMed ID: 22733064
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
Yadav R; Bulitta JB; Wang J; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993331
[TBL] [Abstract][Full Text] [Related]
18. Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
Derbali RM; Aoun V; Moussa G; Frei G; Tehrani SF; Del'Orto JC; Hildgen P; Roullin VG; Chain JL
Mol Pharm; 2019 May; 16(5):1906-1916. PubMed ID: 30900903
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection.
Wang Y; Li C; Wang J; Bai N; Zhang H; Chi Y; Cai Y
Microbiol Spectr; 2022 Oct; 10(5):e0146822. PubMed ID: 36102678
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.
Bergen PJ; Forrest A; Bulitta JB; Tsuji BT; Sidjabat HE; Paterson DL; Li J; Nation RL
Antimicrob Agents Chemother; 2011 Nov; 55(11):5134-42. PubMed ID: 21876058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
